Issue 29, 2024

A highly sensitive ratiometric fluorescence immunoassay based on bioorthogonal nanozymes

Abstract

We designed a novel ratiometric fluorescence immunoassay based on bioorthogonal nanozymes for carcinoembryonic antigen detection. The analytical performance of our designed immunoassay showed a wide linear range, a low detection limit, good reproducibility, selectivity and stability. Thus, bioorthogonal nanozymes hold great potential applications in clinical diagnoses.

Graphical abstract: A highly sensitive ratiometric fluorescence immunoassay based on bioorthogonal nanozymes

Supplementary files

Article information

Article type
Communication
Submitted
17 Feb 2024
Accepted
11 Mar 2024
First published
12 Mar 2024

Chem. Commun., 2024,60, 3978-3981

A highly sensitive ratiometric fluorescence immunoassay based on bioorthogonal nanozymes

X. Liu, N. Wang, Y. Hou, H. Dong, W. Liang, X. Li and Y. Yuan, Chem. Commun., 2024, 60, 3978 DOI: 10.1039/D4CC00731J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements